|
EMF Study
(Database last updated on Mar 27, 2024)
ID Number |
|
168 |
Study Type |
|
Epidemiology |
Model |
|
Mobile phone use and cancer risk. |
Details |
|
Human subjects from Phoenix (Barrow Neurological Institute - Dr. Bill Shapiro), Harvard (Dr. Howard Fine) and Pittsburg (West Pennsylvania Hospital - Dr. Robert Selker) with brain tumors (gliomas [n = 489; 354 high-grade, 135 low-grade], meningioma [n = 197], and acoustic neuroma [n = 96]) were analyzed for cell phone use. The authors conclude that the data does not support a connection between the use of hand-held cellular telephones and brain tumors, although the authors stated that insufficient evidence exists to evaluate the risks of long-term, heavy users or use for long periods of time. In a subsequent study using the same cases and controls (Neuroepidemiolog, 2003, 22:130-138), but not including RF exposure from mobile phone use, the authors looked at brain tumor laterality vs sex, age at diagnosis, marital status at diagnosis, education, income, hospital, handedness, demographics, and presenting symptoms. The authors report some increased high-grade gliomas in men, some differences in average age at diagnosis between low- and high-grade gliomas, and some interesting time-of-diagnosis and laterality associations with marital status. There was a significant left-sided predominance of glioma of unspecified type (12:1). However, overall the authors report no significant difference in laterality of the major tumor types with the above non-RF associated factors. Overall study findings: OR = 0.9 ; 95% CI 0.5-1.6 - glioma (> 100 hrs), OR = 0.7 ; 95% CI 0.3-1.7 - meningioma (> 100 hrs), OR = 1.4 ; 95% CI 0.6-3.5 - acoustic neuroma (> 100 hrs), no ipsilateral association. The group also published earlier studies on occupational exposures (including RF) and leukemia in Sweden.
|
Findings |
|
No Effects |
Status |
|
Completed With Publication |
Principal Investigator |
|
National Cancer Institute, USA
|
Funding Agency |
|
NCI, USA
|
Country |
|
UNITED STATES |
References |
|
Inskip, PD et al. New England J. Med, (2001) 344:79-86
Inskip, PD et al. Rad Prot Dos, (1999) 86:45-52
Inskip, PD et al. Neuroepidemiology, (2003) 22:130-138
Linet, MS et al. Am. J. Ind. Med., (1988) 14:319-330
Linet, MS et al. Rev Environ Health., (2010) 25:51-55
Withrow, DR et al. Cancer., (2021) doi.org/10.1002/cncr.33553:-
|
Comments |
|
Dosimetry was obtained by nurse interview.
AUTHORS' ABSTRACT: Linet and Inskip 2010 (IEEE #5637): An anecdotal 1993 United States (U.S.) television report linking a woman's brain tumor with her cell phone use led Congress to urge the National Cancer Institute to conduct epidemiologic research on brain tumor risks associated with cell phone use. Public concerns
were driven by the dramatic increase in use of a novel technology and the largely unknown
etiology of brain tumors. Cell phones emit radiofrequency energy which is a form of nonionizing radiation. Electromagnetic radiation includes two major types: ionizing or highfrequency radiation (such as that produced by x-ray machines, nuclear energy, radon and
other forms), which has been shown to pose cancer risks, and non-ionizing or low frequency
radiation (such as radiofrequency emitted by cell phones, microwaves or radar or extremely
low-frequency emitted by power lines and many electrical appliances), which is not established as carcinogenic /1,2/. At high power levels, radiofrequency radiation can cause
heating of tissue.
The level of radiofrequency energy produced by cell phones, however, is too low to produce
significant tissue heating or an increase in body temperature /1/. The most common use of
radiofrequency energy is for telecommunications including AM/FM radios, VHF/UHF televisions, cellular telephones, and cordless telephones, which historically operated at lower
radiofrequencies than cellular telephones. Other sources of radiofrequency energy include radar, satellite stations, magnetic resonance imaging devices, microwave ovens, and industrial equipment, all of which operate at higher frequencies than cell phones /1/. Limited
numbers of epidemiologic studies that have evaluated cancer risks associated with exposures
to radiofrequency energy sources other than cell phones have shown null results or a few
inconsistent findings, but often statistical power was insufficient to provide stable risk
estimates for brain tumors, leukemia, or other rare outcomes /1/. There is no consistent
experimental evidence of carcinogenicity or genotoxicity associated with radiofrequency
radiation exposure, and a potential biologic mechanism by which radiofrequency radiation
might cause cancer has not been identified /1/. |
Return
|